The future of cellular therapy for the treatment of renal cell carcinoma
{{output}}
Introduction: Systemic treatment options for renal cell carcinoma (RCC) have expanded considerably in recent years, and both tyrosine kinase inhibitors and immune checkpoint inhibitors, alone or in combination, have entered the c... ...
